Literature DB >> 12685682

Identifying new diseases and their causes: the dilemma of illnesses in Gulf War veterans.

John W Gardner1, Robert V Gibbons, Tomoko I Hooper, Stephen O Cunnion, Kurt Kroenke, Gary D Gackstetter.   

Abstract

Since the Gulf War, investigation continues of symptoms and illnesses among its veterans. Yet, identifying a specific "Gulf War Syndrome" remains elusive. With new disease entities, causal associations are relatively easily established when the condition is serious, verifiable, and has excess disease rates in specific groups. In common conditions, many excess cases are required to establish association with a specific exposure. Establishing causality in syndromes with variable symptoms is difficult because specific diagnostic algorithms must be established before causal factors can be properly investigated. Searching for an environmental cause is futile in the absence of an operational disease case definition. Common subjective symptoms (without objective physical or laboratory findings) account for over one-half of all medical outpatient visits, yet these symptoms lack an identified physical cause at least one-third of the time. Our medical care system has difficulty dealing with disorders where there is no identified anatomic abnormality or documented metabolic/physiological dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 12685682

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

Review 1.  Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management.

Authors:  Kurt Kroenke
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

2.  The long-term hospitalization experience following military service in the 1991 Gulf War among veterans remaining on active duty, 1994-2004.

Authors:  Tomoko I Hooper; Samar F Debakey; Barbara E Nagaraj; Kimberly S Bellis; Besa Smith; Tyler C Smith; Gary D Gackstetter
Journal:  BMC Public Health       Date:  2008-02-13       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.